Shareholding for the Period Ended December 31, 2016
Sun Pharmaceutical Industries Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click here18-01-2017
18-01-2017
Pharma barons swallow FDA bitter pill, Sun Pharma's Shanghvi biggest loser
Combined net worth of country's top 8 pharma promoters down by Rs 42,000 crore since 201516-01-2017
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pratham Investments13-01-2017
Trump is bad for Sun Pharma, here's why
If anything goes wrong drastically, like what Trump said, there needs to be a lot of clarity as it could be very negative for large Indian generic majors, says the analyst.12-01-2017
Sun Pharma announces successful clinical trial for Seciera
Seciera is a patented, proprietary nanomicellar formulation of cyclosporine04-01-2017
Sun Pharma Announces Positive Topline Results of Confirmatory Phase-3 Clinical Trial for Seciera for Treatment of Dry Eye
Sun Pharmaceutical Industries Ltd has informed BSE regarding a Press Release dated January 04, 2017 titled "Sun Pharma Announces Positive Topline Results of Confirmatory Phase-3 Clinical Trial for Seciera for Treatment of Dry Eye".04-01-2017
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mrs Raksha Valia31-12-2016
Sun Pharmaceutical Industries Ltd reply to clarification sought by the exchange
The Exchange had sought clarification from Sun Pharmaceutical Industries Ltd with respect to news appearing in Business Line on December 29, 2016 titled "Blast at sun pharma unit."Sun Pharmaceutical Industries Ltd response is enclosed.29-12-2016